Replicative fidelity of lentiviral vectors produced by transient transfection

Virology

Volumn 348, Issue 2, 2006, Pages 406-417

  Laakso, Meg M ^a   Sutton, Richard E ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

Fidelity; Lentiviral vector; RNA polymerase II; Transient transfection

Indexed keywords

LENTIVIRUS VECTOR; RNA DIRECTED DNA POLYMERASE; RNA POLYMERASE II;

ANALYTIC METHOD; ANALYTICAL ERROR; ARTICLE; AVIAN LEUKOSIS ONCOVIRUS; GENE CASSETTE; GENE CONSTRUCT; GENE MUTATION; GENETIC TRANSFECTION; HUMAN IMMUNODEFICIENCY VIRUS; HYPOTHESIS; LONG TERMINAL REPEAT; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; REVERTANT; VIRUS REPLICATION;

AVIAN LEUKOSIS VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MOLONEY MURINE LEUKEMIA VIRUS;

EID: 33646241507     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2005.12.037     Document Type: Article

References (66)

1. Achaz G., Palmer S., Kearney M., Maldarelli F., Mellors J.W., Coffin J.M., and Wakeley J. A robust measure of HIV-1 population turnover within chronically infected individuals. Mol. Biol. Evol. 21 (2004) 1902-1912
2. Adachi A., Gendelman H.E., Koenig S., Folks T., Willey R., Rabson A., and Martin M.A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59 (1986) 284-291
3. An W., and Telesnitsky A. HIV-1 genetic recombination: experimental approaches and observations. AIDS Rev. 4 (2002) 195-212
4. Arad U. Modified Hirt procedure for rapid purification of extrachromosomal DNA from mammalian cells. BioTechniques 24 (1998) 760-762
5. Bakhanashvili M., Novitsky E., Lilling G., and Rahav G. P53 in cytoplasm may enhance the accuracy of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase. Oncogene 23 (2004) 6890-6899
6. Barre-Sinoussi F. HIV as the cause of AIDS. Lancet 348 (1996) 31-35
7. Batard P., Jordan M., and Wurm F. Transfer of high copy number plasmid into mammalian cells by calcium phosphate transfection. Gene 270 (2001) 61-68
8. Bebenek K., Boyer J.C., and Kunkel T.A. The base substitution fidelity of HIV-1 reverse transcriptase on DNA and RNA templates probed with 8-oxo-deoxyguanosine triphosphate. Mutat. Res. 429 (1999) 149-158
9. Berkhout B., Das A.T., and Beerens N. HIV-1 RNA editing, hypermutation, and error-prone reverse transcription. Science 292 (2001) 7
10. Boyer J.C., Bebenek K., and Kunkel T.A. Unequal human immunodeficiency virus type 1 reverse transcriptase error rates with RNA and DNA templates. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 6919-6923
11. Calos M.P., Lebkowski J.S., and Botchan M.R. High mutation frequency in DNA transfected into mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 3015-3019
12. Chen R., Le Rouzic E., Kearney J.A., Mansky L.M., and Benichou S. Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages. J. Biol. Chem. 279 (2004) 28419-28425
13. Conticello S.G., Harris R.S., and Neuberger M.S. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr. Biol. 13 (2003) 2009-2013
14. De Angioletti M., Rovira A., Sadelain M., Luzzatto L., and Notaro R. Frequency of missense mutations in the coding region of a eukaryotic gene transferred by retroviral vectors. J. Virol. 76 (2002) 1991-1994
15. Domingo E., Menendez-Arias L., and Holland J.J. RNA virus fitness. Rev. Med. Virol. 7 (1997) 87-96
16. Dougherty J.P., and Temin H.M. Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication. J. Virol. 62 (1988) 2817-2822
17. Dupre L., Trifari S., Follenzi A., Marangoni F., Lain d.L., Bernad A., Martino S., Tsuchiya S., Bordignon C., Naldini L., Aiuti A., and Roncarolo M.G. Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction. Mol. Ther. 10 (2004) 903-915
18. Ellis N., and Gallant J. An estimate of the global error frequency in translation. Mol. Gen. Genet. 188 (1982) 169-172
19. Esnault C., Heidmann O., Delebecque F., Dewannieux M., Ribet D., Hance A.J., Heidmann T., and Schwartz O. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature 433 (2005) 430-433
20. Fernandez-Medina D., Jansson M., Rabinovich R.D., Libonatti O., and Wigzell H. Identification of human immunodeficiency virus type 1 subtypes B and F B/F recombinant and dual infection with these subtypes in Argentina. Scand. J. Infect. Dis. 31 (1999) 235-242
21. Goff S.P. Retroviral reverse transcriptase: synthesis, structure, and function. J. Acquired Immune. Defic. Syndr. 3 (1990) 817-831
22. Goff S.P. Death by deamination: a novel host restriction system for HIV-1. Cell 114 (2003) 281-283
23. Goldman C.K., Soroceanu L., Smith N., Gillespie G.Y., Shaw W., Burgess S., Bilbao G., and Curiel D.T. In vitro and in vivo gene delivery mediated by a synthetic polycationic amino polymer. Nat. Biotechnol. 15 (1997) 462-466
24. Golinelli M.P., and Hughes S.H. Nontemplated nucleotide addition by HIV-1 reverse transcriptase. Biochemistry 41 (2002) 5894-5906
25. Hentze M.W., and Kulozik A.E. A perfect message: RNA surveillance and nonsense-mediated decay. Cell 96 (1999) 307-310
26. Huang K.J., and Wooley D.P. A new cell-based assay for measuring the forward mutation rate of HIV-1. J. Virol. Methods 124 (2005) 95-104
27. Ikeda Y., Takeuchi Y., Martin F., Cosset F.L., Mitrophanous K., and Collins M. Continuous high-titer HIV-1 vector production. Nat. Biotechnol. 21 (2003) 569-572
28. Johnson V.A., Brun-Vezinet F., Clotet B., Conway B., Kuritzkes D.R., Pillay D., Schapiro J., Telenti A., and Richman D. Update of the drug resistance mutations in HIV-1. Top. HIV Med. 13 (2005) 51-57
29. Kafri T., van Praag H., Ouyang L., Gage F.H., and Verma I.M. A packaging cell line for lentivirus vectors. J. Virol. 73 (1999) 576-584
30. Kerr S.G., and Anderson K.S. RNA dependent DNA replication fidelity of HIV-1 reverse transcriptase: evidence of discrimination between DNA and RNA substrates. Biochemistry 36 (1997) 14056-14063
31. Koyama H., Ito T., Nakanishi T., Kawamura N., and Sekimizu K. Transcription elongation factor S-II maintains transcriptional fidelity and confers oxidative stress resistance. Genes Cells 8 (2003) 779-788
32. Lebkowski J.S., DuBridge R.B., Antell E.A., Greisen K.S., and Calos M.P. Transfected DNA is mutated in monkey, mouse, and human cells. Mol. Cell. Biol. 4 (1984) 1951-1960
33. Lecossier D., Bouchonnet F., Clavel F., and Hance A.J. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300 (2003) 1112
34. Levy D.N., Aldrovandi G.M., Kutsch O., and Shaw G.M. Dynamics of HIV-1 recombination in its natural target cells. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 4204-4209
35. MacGregor R.R. Clinical protocol. A phase 1 open-label clinical trial of the safety and tolerability of single escalating doses of autologous CD4 T cells transduced with VRX496 in HIV-positive subjects. Hum. Gene Ther. 12 (2001) 2028-2029
36. Mansky L.M. Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell line. AIDS Res. Hum. Retroviruses 12 (1996) 307-314
37. Mansky L.M. The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene. Virology 222 (1996) 391-400
38. Mansky L.M., and Temin H.M. Lower mutation rate of bovine leukemia virus relative to that of spleen necrosis virus. J. Virol. 68 (1994) 494-499
39. Mansky L.M., and Temin H.M. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69 (1995) 5087-5094
40. Mansky L.M., Preveral S., Selig L., Benarous R., and Benichou S. The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate. J. Virol. 74 (2000) 7039-7047
41. Mansky L.M., Le Rouzic E., Benichou S., and Gajary L.C. Influence of reverse transcriptase variants, drugs, and Vpr on human immunodeficiency virus type 1 mutant frequencies. J. Virol. 77 (2003) 2071-2080
42. Mashima Y., Murakami A., Weleber R.G., Kennaway N.G., Clarke L., Shiono T., and Inana G. Nonsense-codon mutations of the ornithine aminotransferase gene with decreased levels of mutant mRNA in gyrate atrophy. Am. J. Hum. Genet. 51 (1992) 81-91
43. Monk R.J., Malik F.G., Stokesberry D., and Evans L.H. Direct determination of the point mutation rate of a murine retrovirus. J. Virol. 66 (1992) 3683-3689
44. Morner A., Bjorndal A., Albert J., KewalRamani V.N., Littman D.R., Inoue R., Thorstensson R., Fenyo E.M., and Bjorling E. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J. Virol. 73 (1999) 2343-2349
45. Nash K.L., Jamil B., Maguire A.J., Alexander G.J., and Lever A.M. Hepatocyte-specific gene expression from integrated lentiviral vectors. J. Gene Med. 6 (2004) 974-983
46. Ni Y., Sun S., Oparaocha I., Humeau L., Davis B., Cohen R., Binder G., Chang Y.N., Slepushkin V., and Dropulic B. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector. J. Gene Med. 7 (2005) 818-834
47. Onafuwa A., An W., Robson N.D., and Telesnitsky A. Human immunodeficiency virus type 1 genetic recombination is more frequent than that of Moloney murine leukemia virus despite similar template switching rates. J. Virol. 77 (2003) 4577-4587
48. O'Neil P.K., Sun G., Yu H., Ron Y., Dougherty J.P., and Preston B.D. Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis. J. Biol. Chem. 277 (2002) 38053-38061
49. Orrantia E., and Chang P.L. Intracellular distribution of DNA internalized through calcium phosphate precipitation. Exp. Cell Res. 190 (1990) 170-174
50. Palzkill T., and Botstein D. Identification of amino acid substitutions that alter the substrate specificity of TEM-1 beta-lactamase. J. Bacteriol. 174 (1992) 5237-5243
51. Rhodes T.D., Nikolaitchik O., Chen J., Powell D., and Hu W.S. Genetic recombination of human immunodeficiency virus type 1 in one round of viral replication: effects of genetic distance, target cells, accessory genes, and lack of high negative interference in crossover events. J. Virol. 79 (2005) 1666-1677
52. Roberts J.D., Bebenek K., and Kunkel T.A. The accuracy of reverse transcriptase from HIV-1. Science 242 (1988) 1171-1173
53. Shriner D., Rodrigo A.G., Nickle D.C., and Mullins J.I. Pervasive genomic recombination of HIV-1 in vivo. Genetics 167 (2004) 1573-1583
54. Soneoka Y., Cannon P.M., Ramsdale E.E., Griffiths J.C., Romano G., Kingsman S.M., and Kingsman A.J. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23 (1995) 628-633
55. Strang B.L., Takeuchi Y., Relander T., Richter J., Bailey R., Sanders D.A., Collins M.K., and Ikeda Y. Human immunodeficiency virus type 1 vectors with alphavirus envelope glycoproteins produced from stable packaging cells. J. Virol. 79 (2005) 1765-1771
56. Sumimoto H., Yamagata S., Shimizu A., Miyoshi H., Mizuguchi H., Hayakawa T., Miyagishi M., Taira K., and Kawakami Y. Gene therapy for human small-cell lung carcinoma by inactivation of Skp-2 with virally mediated RNA interference. Gene Ther. (2004) 95-100
57. Thomas M.J., Platas A.A., and Hawley D.K. Transcriptional fidelity and proofreading by RNA polymerase II. Cell 93 (1998) 627-637
58. Turelli P., and Trono D. Editing at the crossroad of innate and adaptive immunity. Science 307 (2005) 1061-1065
59. van Maanen M., Tidwell J.K., Donehower L.A., and Sutton R.E. Development of an HIV-based cDNA expression cloning system. Mol. Ther. 8 (2003) 167-173
60. Varela-Echavarria A., Garvey N., Preston B.D., and Dougherty J.P. Comparison of Moloney murine leukemia virus mutation rate with the fidelity of its reverse transcriptase in vitro. J. Biol. Chem. 267 (1992) 24681-24688
61. Wang D., and Hawley D.K. Identification of a 3′→5′ exonuclease activity associated with human RNA polymerase II. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 843-847
62. Weickert M.J., and Apostol I. High-fidelity translation of recombinant human hemoglobin in Escherichia coli. Appl. Environ. Microbiol. 64 (1998) 1589-1593
63. Yoshida Y., Emi N., and Hamada H. VSV-G-pseudotyped retroviral packaging through adenovirus-mediated inducible gene expression. Biochem. Biophys. Res. Commun. 232 (1997) 379-382
64. Zhang J., and Maquat L.E. Evidence that the decay of nucleus-associated nonsense mRNA for human triosephosphate isomerase involves nonsense codon recognition after splicing. RNA 2 (1996) 235-243
65. Zhang H., Yang B., Pomerantz R.J., Zhang C., Arunachalam S.C., and Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424 (2003) 94-98
66. Zhuang J., Jetzt A.E., Sun G., Yu H., Klarmann G., Ron Y., Preston B.D., and Dougherty J.P. Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots. J. Virol. 76 (2002) 11273-11282